Target intelligence / Profile preview

WD repeat domain 13 (WDR13)

Target
WDR13
Molecular classification
WD repeat protein family, WD40 domain protein, Scaffold protein, Other (beta propeller fold protein)
01

Overview

WD repeat domain 13 (*WDR13*) encodes a member of the WD repeat protein family, which is characterized by multiple WD repeat motifs, each approximately 40 amino acids long often ending with a tryptophan-aspartic acid pair[3][1][4]. WDR repeat proteins, including WDR13, adopt a beta propeller fold and serve as stable platforms for the assembly of multiprotein complexes, facilitating processes such as cell cycle progression, signal transduction, apoptosis, and gene regulation without intrinsic catalytic activity[1][4]. WDR13 is thought to negatively regulate pancreatic beta cell proliferation (based on mouse studies), with gene knockout resulting in increased pancreatic islet mass and higher serum insulin and mild obesity[3]. WD repeat domain proteins are involved in numerous cellular processes but are not typically considered direct drug targets due to the lack of enzymatic activity or classical ligand binding[4].

Other names
WD repeat-containing protein 13MG21WDR13
02

Mechanism of action

Not applicable; no drugs are known to specifically target WDR13. The protein acts primarily as a scaffold in multiprotein complexes.

03

Biological functions

Signal transductionCell cycle regulationApoptosisGene regulationProtein complex assembly
04

Disease associations

Cancer (proposed)Diabetes/metabolic syndrome (regulates pancreatic beta cell proliferation; deletion increases islet mass and insulin)Neurodevelopmental disorders (Alacrima, Achalasia, And Impaired Intellectual Development Syndrome; Autism Spectrum Disorder)Other (possible regulatory involvement in diverse cellular processes)
05

Safety considerations

No specific safety concerns or challenges identified related to targeting WDR13, but deletion in animal models produces mild obesity and increased insulin, suggesting possible metabolic effects if suppressed[3].

Beyond the preview

Go deeper on WD repeat domain 13 (WDR13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WD repeat domain 13 (WDR13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call